Feasibility of multiomics tumor profiling for guiding treatment of melanoma
Nicola Miglino(University Hospital of Zurich), Faisal Alquaddoomi(Roche (Switzerland)), Jonas Albinus(SIB Swiss Institute of Bioinformatics), Marina Tusup(University of Zurich), Sujana Sivapatham(University of Zurich), Franziska Singer(SIB Swiss Institute of Bioinformatics), Lars Bosshard(SIB Swiss Institute of Bioinformatics), Natalia Chicherova(University of Zurich), Daniel Baumhoer(University Hospital of Basel), Beatrice Beck‐Schimmer(University Hospital of Zurich), Kjong-Van Lehmann(SIB Swiss Institute of Bioinformatics), Cinzia Esposito(University of Zurich), Lara Bernasconi(University Hospital of Zurich), Alexander Ring(University Hospital of Zurich), Laura Amanda Boos(University Hospital of Zurich), Bettina Sobottka(University Hospital of Zurich), Shuqing Yu(SIB Swiss Institute of Bioinformatics), Melike Ak(ETH Zurich), Michael Prummer(SIB Swiss Institute of Bioinformatics), Sandra Goetze(ETH Zurich), Jack Kuipers(SIB Swiss Institute of Bioinformatics), Ruben Casanova(University of Zurich), Francis Jacob(University of Basel), Per-Olof Attinger(University of Zurich), Pedro Ferreira(SIB Swiss Institute of Bioinformatics), Anja Frei(University Hospital of Zurich), Gabriele Gut(University of Zurich), Ximena Bonilla(Universidad de Salamanca), Ilaria Alborelli(ETH Zurich), Anne Bertolini(University Hospital of Zurich), Ulrike Lischetti(University of Basel), Anja Irmisch(University of Zurich), Stéphane Chevrier(University of Zurich), Emanuela S. Milani(Board of the Swiss Federal Institutes of Technology), Benedict Gosztonyi(University Hospital of Zurich), Tarun Mehra(University Hospital of Zurich), Julien Mena(ETH Zurich), Nora C. Toussaint(SIB Swiss Institute of Bioinformatics), Jacobo Sarabia del Castillo(University of Zurich), Monica-Andreea Baciu-Drăgan(SIB Swiss Institute of Bioinformatics), Marta Nowak(Roche (Switzerland)), Silvana I. Albert(ETH Zurich), Parisa Rahimzadeh(University Hospital of Zurich), Rebekka Wegmann(ETH Zurich), Manuel Schuerch(University Hospital of Zurich)
Cited by 15
Related Papers
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
|Nature Genetics|2016|495
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
|Nature Communications|2020|383